Jardiance is the focus of this plain-language guide to its uses, expected effects, and safety considerations. Because it relates to diabetes and metabolic health, details such as age, other health conditions, pregnancy status, and medicines taken at the same time may affect whether it is suitable. Read the relevant sections alongside the official product leaflet, and ask a qualified clinician or pharmacist about decisions that apply to you.
The drug works through the kidneys rather than the pancreas: it blocks a transporter that normally pulls glucose back into the blood, so extra sugar leaves the body in the urine. That mechanism lowers blood sugar steadily without forcing insulin output, and researchers believe related effects on fluid balance and filtering pressure help explain the heart and kidney benefits.
This article covers the approved uses in detail, how empagliflozin works, and the safety issues specific to SGLT2 inhibitors — genital and urinary infections, ketoacidosis that can occur with near-normal glucose, a rare perineal infection called Fournier’s gangrene, and volume depletion. Hydration habits and infection prevention also get attention, along with how Jardiance relates to its closest sibling, Farxiga.
What Is Jardiance?
Jardiance is the brand name for empagliflozin, an oral prescription medicine in the SGLT2 inhibitor class, short for sodium-glucose cotransporter 2 inhibitor. These drugs act on a recycling protein in the kidneys, and the class is sometimes nicknamed “flozins.” Jardiance itself is a plain tablet taken by mouth once daily, with no injection involved.
Empagliflozin also appears in fixed-dose combination tablets that pair it with other diabetes medicines, so pharmacy labels can look different depending on the product. Check the ingredient list on your prescription, and tell every provider which version you take. The information in this article applies to empagliflozin alone; combination products carry additional considerations from their second ingredient.
What Is Jardiance Used For?
Jardiance is FDA-approved to lower blood sugar in adults with type 2 diabetes as part of a broader plan that includes diet and exercise. It is not approved for type 1 diabetes, where the pancreas produces little or no insulin, because that condition carries a high risk of ketoacidosis and needs insulin-based care.
The label extends into heart and kidney territory. For adults with type 2 diabetes and established cardiovascular disease, Jardiance is approved to reduce the risk of cardiovascular death. It is also approved to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure, and current labeling covers additional heart failure populations following label expansions in recent years — ask your prescriber or check the current label for the exact groups included. Separately, the label addresses kidney-related risk reduction in adults with chronic kidney disease who are at risk of progression, again subject to the details of current labeling.
Eligibility for each use depends on the diagnosis, kidney function, and other medicines, so the approved “box” you fall into is a clinical decision. People sometimes assume Jardiance is a weight-loss or blood-pressure drug because of side benefits observed in studies; those are not approved purposes on their own.
How Does Jardiance Work?
Inside each kidney, millions of filters clean the blood and a transporter called SGLT2 then reclaims glucose from the filtered fluid so none is wasted. Empagliflozin blocks that transporter. The result is that a meaningful amount of glucose exits through the urine instead of returning to the bloodstream, and blood sugar falls accordingly.
Because the effect does not depend on squeezing more insulin from a tired pancreas, it works in early and late type 2 diabetes alike, and it carries a low risk of hypoglycemia when Jardiance is used by itself. The sugar loss also pulls water with it, producing mild urination and a gentle drop in fluid volume. Studies suggest that shift, together with improved heart efficiency and lowered pressure inside the kidney’s filters, underlies the heart-failure and kidney benefits that trials documented. Typical A1C reductions are moderate and depend on starting levels, kidney function, and whatever else is in your regimen.
Available Forms and Strengths
Jardiance comes as oral tablets in two strengths, 10 mg and 25 mg. Prescribers choose the starting strength and decide whether an increase is worthwhile, with kidney function playing a central role in that choice. Reduced kidney function changes both how well the drug lowers glucose and which approved uses remain appropriate, so your prescriber tracks lab work rather than treating this as a one-size decision.
| Strength | Form | Frequency | Notes |
|---|---|---|---|
| 10 mg | Film-coated tablet | Once daily | Common starting point; also the dose studied for heart and kidney outcomes |
| 25 mg | Film-coated tablet | Once daily | Optional step-up when more glucose lowering is needed |
Do not change strengths on your own. The difference between the two is real, and kidney numbers often determine whether the higher dose adds value or simply adds exposure. Strength changes, when they happen, usually follow several weeks of use and a lab review rather than an immediate swap.
How to Take Jardiance
Take one tablet once a day, with or without food, at a time you can remember consistently. Many people choose the morning because the drug increases urination, and daytime dosing keeps bathroom trips from disturbing sleep. Swallow the tablet whole with water and leave dose changes to your prescriber. No food rules apply, but pairing the tablet with breakfast or another daily anchor helps keep the streak unbroken.
Missed Dose
If you forget a dose, take it the same day when you remember; if the next dose is already close, skip the missed one and continue normally. Doubling up is never recommended. Steady daily use matters more than perfect timing for this class, because the sugar-lowering effect resets each day.
Overdose and Emergency Help
Taking too much empagliflozin can drive excessive urination, dehydration, and dropping blood pressure, and low blood sugar is possible if insulin or a sulfonylurea is also in the mix. Contact Poison Control at 1-800-222-1222 or seek emergency care after an overdose, and bring the medication container with you.
Common Jardiance Side Effects
The side effects that define this class all trace back to one mechanism: glucose in the urine. Sugar is a growth medium for yeast and bacteria, so infections in the genital and urinary tracts become more likely. Fluid shifts explain the rest of the common list.
| More frequent | Reported less often |
|---|---|
| Genital yeast infections in women and men | Lightheadedness when standing, from mild fluid loss |
| Urinary tract infections | Rises in LDL cholesterol noted on the label |
| Increased urination, especially early on | Nausea or general digestive upset |
| Increased thirst | Back pain or nasal congestion in trial reports |
Good genital hygiene, prompt treatment of any infection, and sensible fluid intake per your prescriber’s guidance address most of these issues. Report burning with urination, unusual discharge, itching, or pelvic discomfort rather than waiting, because infections respond best to early care.
Serious Side Effects and Warnings
Ketoacidosis is the headline warning. Diabetic ketoacidosis is a dangerous buildup of blood acids, and with SGLT2 inhibitors it can occur while glucose readings look near normal — the term is euglycemic diabetic ketoacidosis. Risk runs higher around surgery, acute illness, severely restricted carbohydrate or ketogenic diets, heavy alcohol use, and skipped meals. Warning signs include nausea, vomiting, stomach pain, unusual tiredness, and labored breathing, and they warrant urgent evaluation even if your glucose meter looks reassuring. Prescribers often pause the drug before surgery or during major illness, so follow their instructions about temporary stops.
A rare but grave infection called Fournier’s gangrene, a flesh-eating infection of the area between the genitals and anus, has been reported with this class. Seek emergency care for sudden pain, tenderness, swelling, redness, or fever in that region. It is uncommon, but delay makes it worse.
- Volume depletion and low blood pressure, especially in people using diuretics, eating low-salt diets, or living with kidney problems — watch for dizziness, fainting, or weakness
- Kidney function changes, which prescribers monitor with routine blood tests and which occasionally require stopping the drug
- Serious allergic reactions, including swelling of the face or throat, which need emergency treatment
- Hypoglycemia when Jardiance is combined with insulin or sulfonylureas, managed by dose adjustments and monitoring
None of these risks is a reason for panic; they are reasons for awareness, hydration, hygiene, and scheduled lab work. Most people on this class take it for years without serious events.
Who Should Use Jardiance with Caution?
Certain situations change the risk math. An honest conversation with your prescriber about the following factors prevents most avoidable problems.
Drug Interactions
Diuretics stack fluid loss on top of Jardiance’s own, so doses and lab work need attention. Insulin and sulfonylureas raise hypoglycemia risk in combination, and prescribers frequently reduce those doses when adding an SGLT2 inhibitor. The label also flags certain enzyme-inducing medicines, such as rifampin, that can lower empagliflozin levels and blunt its effect. Bring a complete list of prescriptions, supplements, and herbal products to each visit so interactions are caught early.
Pregnancy and Breastfeeding
SGLT2 inhibitors are generally avoided during pregnancy, particularly in the later stages, because they are not appropriate for managing diabetes in that setting. If you become pregnant while taking Jardiance, contact your prescriber promptly to arrange a switch. Breastfeeding also calls for a different plan, since it is not established that empagliflozin is safe for a nursing infant.
Use in Children and Older Adults
Approved uses described in the label center on adults, so families of younger patients should confirm with a specialist what current labeling permits. Older adults deserve closer attention to hydration, blood pressure on standing, urinary symptoms, and kidney numbers, because volume depletion and infections are easier to miss in this group. Dose decisions should always follow current kidney function rather than age alone.
Storage and Handling
Store Jardiance tablets at room temperature in a dry place, ideally in the original container with the lid closed. Bathrooms are humid, so a bedroom drawer or kitchen cabinet away from the stove is often better. Keep the medication out of reach of children and pets, and dispose of expired tablets through a pharmacy take-back program or another recommended channel. If you use a weekly pill organizer, confirm the tablets stay dry and keep the original container for reference.
How Quickly Does Jardiance Work?
Glucose begins appearing in the urine from the first doses, and blood sugar improvements typically show within days to weeks, with A1C checked after about three months to judge the full effect. Heart-failure and kidney benefits develop over longer horizons; in trials they emerged across months to years of follow-up, which is why this medicine is viewed as a long-term protective therapy rather than a quick fix. Benefits persist as long as the drug is taken and generally fade after it stops. Because heart and kidney end points mature slowly, prescribers judge this medicine on years of use, not weeks of readings.
Jardiance and Farxiga: Sibling Pills with Overlapping Roles
Farxiga, which contains dapagliflozin, is the closest relative of Jardiance: same class, same once-daily tablet format, and overlapping approvals across diabetes, heart failure, and chronic kidney disease. Differences live in the details of labeling, available strengths, and study populations, so neither is universally “better.” Insurance coverage frequently decides the choice, and kidney function may tip it.
Other alternatives exist as well. Canagliflozin is a third SGLT2 inhibitor with its own label. Metformin remains a common foundation therapy for type 2 diabetes, GLP-1 injections such as Ozempic or Trulicity offer strong A1C and cardiovascular effects, and DPP-4 inhibitors provide gentle glucose lowering. The right mix depends on your organs, goals, tolerances, and budget, which is a discussion worth having with your clinician rather than a choice made from advertising.
Frequently Asked Questions
Why does Jardiance increase the risk of infections?
The drug sends glucose into the urine, and microbes thrive on sugar. Genital yeast infections and urinary tract infections therefore occur more often, in both women and men. Hygiene, hydration, and early treatment keep most cases minor.
Can I follow a ketogenic diet while taking Jardiance?
Discuss it with your prescriber first. Severely restricted carbohydrate intake is one of the recognized risk settings for euglycemic ketoacidosis, the form that arrives with near-normal glucose readings and can be missed at home.
Does Jardiance cause weight loss?
Modest weight-related changes are common because calories leave as glucose in the urine, but Jardiance is not a weight-loss drug and expectations should stay realistic. Dedicated weight-management treatments exist for that goal.
Can Jardiance help my heart if I do not have diabetes?
Current labeling includes heart failure indications that extend beyond people with diabetes, and label expansions in recent years have broadened coverage — confirm with your prescriber whether your specific diagnosis is included. The heart and kidney benefits come from the drug’s effects on fluid handling and filtration pressure, not from glucose removal alone.
Should I stop Jardiance before surgery or when I get sick?
Often yes, but only on instruction from your care team. Surgery, vomiting, poor intake, and acute illness raise ketoacidosis risk, so prescribers commonly pause the tablet temporarily and restart it once you are stable and eating again.
What happens if my kidney function declines?
Your prescriber will recheck lab work periodically and reassess dose and eligibility, because kidney numbers influence both glucose lowering and which approved uses remain valid. A decline does not always mean stopping; it means recalculating.
Conclusion
Jardiance turned a clever kidney mechanism into a medicine that serves three organ systems at once: steadier glucose for adults with type 2 diabetes, documented cardiovascular protection, and kidney-related risk reduction under current labeling. Its trade-offs — genital and urinary infections, ketoacidosis awareness, and hydration vigilance — are manageable with routine care. If you have diabetes, heart failure, or chronic kidney disease, ask your prescriber whether empagliflozin belongs in your plan and how it compares with its sibling, Farxiga.
Medical Disclaimer
General information cannot cover every individual situation.
Medical Disclaimer: This article is for informational and educational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Follow the official product instructions and seek urgent medical assistance for a medical emergency.
References and Sources
- DailyMed — Jardiance Drug Information — official FDA label covering indications, warnings, and dosing.
- Jardiance Official Site — manufacturer resources on uses, savings, and patient support.
- Drugs@FDA — approval history and labeling records for empagliflozin.
- MedlinePlus — Drug Information — consumer-level drug profiles and safety explanations.